Watson raises EPS guidance after strong first quarter
This article was originally published in Scrip
Executive Summary
Watson Pharmaceuticals' total revenues in the first quarter jumped by 28% to $857 million, leading it to raise the bottom line of its 2010 EPS guidance by 20 cents.